A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID

• Main Authors: Yun-chao Xu (Author), Xu Liu (Author), Min Li (Author), Yan Li (Author), Chun-yan Li (Author), Ying Lu (Author), Jaceline Sanches (Author), Lu Wang (Author), Yue Du (Author), Li-min Mao (Author), Si-bo Zuo (Author), Hui-ting Liu (Author), Jie Shen (Author), Bo Wang (Author), Li Hou (Author), Lian-hong Li (Author), Jian-wu Tang (Author), Jing-fang Ju (Author), Hong-wei Guan (Author), Bo Song (Author)
• Format: Book
• Published: Elsevier, 2018-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Doxorubicin is a widely used anthracycline-based anti-tumor agent for both solid and liquid tumors. Mounting evidence has demonstrated that microRNAs (miRNAs) are involved in chemoresistance and tumorigenesis. However, the roles of microRNA-501-5p (miR-501) in doxorubicin resistance and gastric canc...